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Mycoplasma gallisepticum, the most pathogenic mycoplasma in poultry, is able to glide over solid surfaces. Although
this gliding motility was first observed in 1968, no specific protein has yet been shown to be involved in gliding. We
examined M. gallisepticum strains and clonal variants for motility and found that the cytadherence proteins GapA and
CrmA were required for gliding. Loss of GapA or CrmA resulted in the loss of motility and hemadsorption and led to
drastic changes in the characteristic flask-shape of the cells. To identify further genes involved in motility, a transposon
mutant library of M. gallisepticum was generated and screened for motility-deficient mutants, using a screening assay
based on colony morphology. Motility-deficient mutants had transposon insertions in gapA and the neighbouring
downstream gene crmA. In addition, insertions were seen in gene mgc2, immediately upstream of gapA, in two
motility-deficient mutants. In contrast to the GapA/CrmA mutants, the mgc2 motility mutants still possessed the
ability to hemadsorb. Complementation of these mutants with a mgc2-hexahistidine fusion gene restored the motile
phenotype. This is the first report assigning specific M. gallisepticum proteins to involvement in gliding motility.Introduction
Motility is regarded as a virulence factor in many patho-
genic bacteria. The ability to move enables microorgan-
isms to reach a specific niche or to leave hostile
environments. Amongst motile bacteria, various mecha-
nisms to create a momentum have evolved. In Bordetella
bronchiseptica, Escherichia coli, and Salmonella enterica
serovar Typhimurium flagellar motility has been shown
to be crucial for the initial stages of infection, while in
Legionella pneumophila motility is necessary to establish
and maintain infection [1]. In contrast to these species,
in which motility can be downregulated to favor a
specific life-style, some bacteria, such as Helicobacter,
Campylobacter, and Pseudomonas aeruginosa, depend
on constitutive flagellar motility for successful infection
[1]. Experiments showing that only motile bacteria can
be reisolated after infection with a mixed population of
motile and non-motile variants underline the import-
ance of motility in the infection process [2].
Mycoplasmas lack a cell wall and are considered to be
the smallest self-replicating microorganisms. They have
limited biosynthetic capabilities as they are highly adapted* Correspondence: michael.szostak@vetmeduni.ac.at
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unless otherwise stated.to a parasitic life-style [3]. In spite of the many limitations
that have resulted from their degenerative evolution, some
mycoplasmas have the ability to travel over inert surfaces,
like glass, plastic or over eukaryotic cells, even though they
lack any obvious locomotory appendages such as flagella
or pili [4].
Mycoplasma gallisepticum is an avian pathogen caus-
ing chronic respiratory disease in chickens and infec-
tious sinusitis in turkeys, that is known to possess
gliding motility. Like the majority of gliding mycoplas-
mas, M. gallisepticum belongs to the M. pneumoniae
cluster [5], named after M. pneumoniae, the causative
agent of human bronchitis and atypical pneumonia [6].
The mechanism that enables M. pneumoniae and other
mycoplasmas to glide has been the subject of a number
of studies [7].
The best studied gliding mechanism is that of M. mo-
bile, isolated from the gills of a fresh-water fish [8],
which is phylogenetically distant from the pneumoniae
cluster. M. mobile can be cultivated at room temperature
and its average gliding speed is 2 to 4.5 μm/s [9], thus
visualization of the gliding process is not dependent on
additional microscope equipment such as a plate heater
or a computer-connected CCD video camera. Several
proteins of M. mobile have been identified as motility
proteins [10]. Centered at the neck region of the jellyfishl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sialylated oligosaccharides on glass or animal cells.
Together with the Gli521 gear protein and the Gli123
mount protein, a large number of legs may act in a con-
tinuous “bind, pull, and release” mode, thereby creating
a continuous pull in the forward direction. The multiple
legs involved suggested the term “centipede-like” loco-
motion [11].
However, no homologs of these M. mobile motility
genes have been found in M. pneumoniae or M. gallisepti-
cum, indicating that different mycoplasmas may have devel-
oped different gliding machineries. The motile members of
the M. pneumoniae cluster share a characteristic morpho-
logical feature, cellular polarity. These mycoplasmas have a
flask-shaped appearance, strengthened by a cytoskeleton,
and have a differentiated tip structure, often called the
attachment tip or terminal organelle (TO). In M.
pneumoniae, the TO mediates adherence to the host
respiratory epithelium, a prerequisite for successful
colonization [12]. In addition, the TO is the leading
end in gliding motility [13], as cells always glide in the
direction of the tip structure.
Formation of the TO appears to be a complex process
that has to be well orchestrated, chronologically and
spatially [14]. The TO of M. pneumoniae consists of a
network of cytadherence proteins, including P1, P30, the
accessory proteins P65, B, C, and the structural proteins
HMW1, HMW2, and HMW3 [15]. Mutations affecting
cytadherence or the correct assembly of the TO have
direct effects on gliding motility. Loss of proteins P1, P30,
or P65 lead to a non-motile, as well as hemadsorption-
negative, phenotype [16]. Similarly, mutations in the TO
proteins P41 and P24 have an impact on the velocity
and frequency of gliding [17]. Although several ele-
ments of the gliding machinery have been identified, it
is still unclear how these motility-associated proteins
work in concert to generate a propulsive force and
move the cell forward.
Studies to elucidate the motility mechanisms of mem-
bers of the pneumoniae cluster have also included M.
genitalium, a close relative of M. pneumoniae. Their
proteins share a high degree of homology [18]. Many of
the proteins involved in M. pneumoniae motility have
counterparts in M. genitalium [19]. Surprisingly, no pro-
tein involved in motility has yet been identified in
M. gallisepticum, and although M. gallisepticum was
included in a recent study of mycoplasma gliding [20],
little is known about the proteins involved. Therefore,
we examined the gliding ability of M. gallisepticum
strain R and clonal variants of it, including a library of
transposon insertion mutants. The aim of this study was
to identify proteins that contribute to the motility
process of M. gallisepticum, to investigate the molecular
properties of such motility proteins, and to further refinethe tools for screening and complementing motility
mutants.
Materials and methods
Strains and growth conditions
M. gallisepticum strains Rlow, Rhigh [21], RCL1, RCL2,
mHAD3 [22], motility mutants and complemented
motility mutants were cultured in modified Hayflick
medium [23] (HFLX) at 37 °C. To grow tetracycline-
(TcR) or chloramphenicol- resistant (CmR) M. gallisep-
ticum transformants, either Tc (4 μg mL−1; Roche
Diagnostics, Penzberg, Germany) or Cm (17 μg mL−1;
Carl Roth GmbH & Co KG, Karlsruhe, Germany) were
added to HFLX medium. Escherichia coli DH10B
(Invitrogen Corp., Carlsbad, CA, USA) was used for
the propagation of plasmids used in this study.
Motility assays
To detect satellite growth of M. gallisepticum, a freshly
grown culture was seeded in a 24-well microtiter plate
at a concentration of 40 CFU per 400 μL of HFLX
medium per well. After 2 h of attachment, the medium
was replaced by HFLX containing 2% gelatin and, if
transformants were to be analyzed, Tc was added to the
HFLX-gelatin mixture. Colony morphology was exam-
ined after growth at 37 °C for five to seven days using an
SMZ-U stereomicroscope (Nikon Corp., Tokyo, Japan).
Characterization of M. gallisepticum gliding motility
was performed using a microcinematography motility
assay (MMA). For this purpose, 100 μL of a culture
freshly grown in HFLX medium was placed on a stand-
ard microscope glass slide (Thermo Fisher Scientific
Inc., Waltham, MA, USA). After 1 h of incubation at
37 °C, attached cells were overlaid with 100 μL of fresh
medium containing 2% gelatin. After 1.5 h of incubation,
cell movement was examined using an Olympus AX70
microscope equipped with a heating plate set at 37 °C,
and phase-contrast images were captured at 1-s intervals
for a total of 180 s with a Color View CCD digital cam-
era controlled using CellPlus (Olympus Soft Imaging So-
lutions GmbH, Muenster, Germany).
Computer-assisted qualitative analysis of motility was
performed by overlaying 180 single frames of a 3 min
microscope movie with the Z project tool of the Fiji
image processing package [24], choosing “Minimum
Intensity” as the critical parameter. Bacterial paths
were highlighted by standard layer manipulations using
Photoshop CS3 version 10.0 (Adobe Systems Inc., San
Jose, CA, USA).
For a quantitative analysis of motility, the ten myco-
plasmas with the longest Z project paths in each field of
view were selected, and their movements were tracked
using the ImageJ/Fiji MTrackJ plugin [25]. Using the
analysis tool of MTrackJ, the distance travelled and the
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determined. The best three results of 5 independent ex-
periments were chosen for graphical representation.
Results of quantitative MMAs were analyzed for statis-
tical significance by using a two-tailed Student’s T test
[26]. P values of ≤ 0.05 were considered to indicate sig-
nificant differences between groups.
DNA isolation and sequencing reactions
Genomic DNA from mycoplasmas was isolated using
the GenElute™ Mammalian Genomic DNA Miniprep Kit
(Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany).
Plasmid DNA from E. coli cultures was purified using
the PureYield™ Plasmid System Kit (Promega, Mannheim,
Germany). Oligonucleotide synthesis was performed by
either Microsynth (Microsynth AG, Balgach, Switzerland)
or Invitrogen (Life Technologies GmbH, Darmstadt,
Germany), and DNA sequencing was conducted by
LGC Genomics (LGC Genomics GmbH, Berlin, Germany).
If not otherwise mentioned, all enzymes used in this study
were purchased from Promega. For DNA/PCR purification,




To use transposon mutants in gentamicin-based cell
invasion assays, we first had to replace the gentamicin
resistance gene of Tn4001. The chloramphenicol-resistance
cassette CmR of plasmid pACYC184 (Invitrogen) was amp-
lified using primers Xcat5 and Xcat3, introducing BamHI
and NarI cleavage sites, respectively. The purified amplicon
was cloned into the corresponding sites of plasmid
p5TlacZ + [27], thereby placing the CmR cassette under the
control of tufPO in plasmid p5xCAT. Left (ISL) and right
(ISR) IS256 elements of S. aureus transposon Tn4001mod
were amplified from plasmid pISM2062 [28], using primers
ISR-f and ISR-r, which introduced MluI and KasI cleavage
sites, and ISL-f and ISL-r, which contained SacII and SalI
cleavage sites. The amplicons ISL and ISR were cloned into
the corresponding sites to the right and to the left end, re-
spectively, of the CmR cassette on plasmid p5xCAT. Trans-
formants of E. coli DH10B were selected on Luria-Bertani
agar containing Cm (30 μg/mL). Transposon mutants of
M. gallisepticum were stable for at least 20 passages with-
out Cm and no re-transposition or excision of Tn4001cam
could be detected (data not shown).
Integration plasmid p5Hmgc
Tn4001mod on plasmid pISM2062 [28] was modified by
adding a 6xHis-tag and a multiple cloning site: a 51-bp
DNA fragment, created by annealing oligonucleotides
HisC-f and HisC-r, was inserted between the BamHI
and SmaI cleavage sites of pISM2062, resulting inplasmid pTnHis. The M. gallisepticum gene mgc2 was
then amplified by PCR using genomic DNA of strain
Rlow as template and primers ISM-mgcF and ISM-
mgcR, and subcloned into pTnHis using the BamHI and
SphI cleavage sites. The resulting plasmid, pTHmgc, was
linearized with NotI, treated with the Klenow fragment
of DNA polymerase I (New England Biolabs GmbH,
Frankfurt/Main, Germany) to fill in the 5′ overhang, and
subsequently digested with BamHI. A 1093-bp fragment
was gel-purified and ligated to a 3.5-kb fragment of plas-
mid pINT [27], obtained after digestion with BamHI
and SfoI.
Transformation of mycoplasmas
M. gallisepticum transposon mutants were generated by
electroporation of strain RCL1 with 3–5 μg of pTnC, as
described previously [22]. For the transformation with
integration plasmid p5Hmgc, 20–30 μg of plasmid DNA
was used. Following electroporation, mycoplasma cells
were cultured on HFLX plates containing either 17.5 μg
chloramphenicol mL−1 or 4 μg tetracycline mL−1.
Ligation mediated PCR (LM-PCR)
Transposon insertion sites were determined by LM-PCR
using the method of Sharma et al. [29], with modifica-
tions. Briefly, genomic DNA of M. gallisepticum trans-
poson mutants was digested with BglII, and ligated to
the BglII-adaptors Ad1B and Ad2B. Prior to ligation, the
adaptor oligo nucleotides were dissolved separately in
double distilled water at a concentration of 100 μM and
equal volumes of both were mixed together. The mix-
ture was incubated at 70 °C for 10 min, allowed to cool
gradually to 40 °C, and then incubated at 40 °C for
10 min. The mixture was then cooled gradually to 25 °C
and stored frozen in small aliquots until further usage.
The ligation product was used as a template for PCR
amplification using the adaptor-specific primer Bgl and
primer IS-I, specific for IS256 of Tn4001mod. The PCR
product was then used as template for a semi-nested
PCR using primers Bgl and IS-N, and the gel-purified
amplicons were sequenced (Microsynth).
Production of antibodies
MGC2
The full-length mgc2 gene was amplified using the LR-
PCR kit (Roche) and primers mgc2_3 and mgc2_4
(Table 1), introducing EcoRI and HindIII cleavage sites
at either end. The TGA codon was mutagenized to TGG
using primer mgc_tga and the Site-directed Mutagenesis
kit (Stratagene) according to the manufacturer’s instruc-
tions. The mutated mgc2 gene was then cloned between
the EcoRI and HindIII cleavage sites in pRSET (Invitrogen)
and introduced into E. coli BL21 (DE3)pLys Star (Invitro-
gen). Expression of MGC2 was induced by addition of
Table 1 Oligonucleotides used in this study






























Xcat5 TAGATGggatccATGGAGAAAAAAATCACTG pACYC184 (751)
Xcat3 ATAAATggcgccCGCTTATTATCACTTATTC CmPO + CmR
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the protein was purified using the MagneHis™ Protein Puri-
fication System (Promega) and immobilized metal affinity
chromatography using ProBond™ nickel-chelating resin
(Invitrogen) according to the manufacturers’ instructions.
Purity of the MGC2 protein was confirmed by Western
blotting using Anti-Xpress™ antibodies (1:5000) (Invitro-
gen). After elution and dialysis against phosphate-buffered
saline (PBS), the protein was used for immunization of rab-
bits as described elsewhere [30].
C-GapA
The 3′-terminal part of the gapA gene was amplified
using the LR-PCR system (Roche) and primers C’gapA5
and C’gapA3, introducing BamHI and HindIII cleavage
sites, at either end. The gel-purified amplicon was li-
gated into plasmid pRSET-B (Invitrogen) and the result-
ing plasmid was introduced into E. coli BL21 (DE3)pLys
Star (Invitrogen). The recombinant culture was grown at
28 °C, and gene expression was induced by addition of
0.3 mM IPTG at the early logarithmic growth phase. A
protein of 35 kDa was retrieved from a sodium dodecyl
sulfate polyacrylamide (SDS-PAA) gel after negative
staining with a zinc stain and destain kit (BioRadLaboratories Inc., Hercules, CA, USA) and electroelution in
an Electro-Eluter Model 422 (BioRad). The immunization
of rabbits with the purified C-terminal part of GapA
followed exactly the same procedures as for MGC2
antibodies.
CrmA
The generation of CrmA-specific antibodies has been
described previously [30].
Western blot analyses and tryptic digestion
Five millilitre aliquots of overnight cultures of mycoplas-
mas were centrifuged at 4200 g for 30 min, and the cell
pellets washed once with PBS and resuspended in PBS
containing 0.05% of a commercial trypsin/EDTA solu-
tion (Life Technologies, #15400). Control samples were
treated in the same way but without trypsin. The sam-
ples were incubated at 37 °C, 1-mL samples removed
after 10, 30, 40, 50, 70 and 90 min, and trypsin activity
stopped by adding phenylmethylsulfonyl fluoride (PMSF)
at a final concentration of 1 mM. Cells were then col-
lected by centrifugation and the presence of MGC2 was
assessed by Western blot analysis. The solubilization and
separation of mycoplasma cell lysates using 10% SDS-
PAA gel electrophoresis, and Western blot analysis is
described elsewhere [31]. Membranes were probed with
antibodies against MGC2 (1:500), GapA (1:6000), or
CrmA (1:2000) using peroxidase-conjugated swine-anti-
rabbit IgG (1:2000, Dako) as secondary antibody, or with
anti-6xHis antibody (1:6000, Aviva Systems Biology
Corp., San Diego, CA, USA) in combination with the
AffiniPure Goat Anti-Mouse IgG, Fc Fragment specific
(1:10 000, Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA, USA).
Hemadsorption assay
The ability of mycoplasma colonies grown on HFLX
agar plates to hemadsorb was tested as described previ-
ously [30].
Scanning electron microscopy (SEM)
Mycoplasma samples for SEM were prepared as de-
scribed previously [32], except that mycoplasma cultures
were grown at 37 °C on glass coverslips, precoated with
poly-L-lysine (Sigma-Aldrich) according to the manufac-
turer’s instructions.
Results
Identification of non-motile M. gallisepticum strains
To establish a method for screening for motility mutants of
M. gallisepticum, we first identified motile and non-motile
strains in our culture collection. Gliding of M. mobile and
M. pneumoniae depends on cytadherence-associated com-
ponents [16,33,34]. Therefore, we analyzed selected strains
Figure 1 Gliding paths of motile M. gallisepticum. A stack of
phase-contrast pictures of M. gallisepticum RCL1, captured at 1-s
intervals, was manipulated with Fiji by applying a Z projection
method [24] to visualize the paths of gliding mycoplasmas.
Differential colouring of mycoplasmas (red) and their paths
(green) was done with Adobe Photoshop. This qualitative
microcinematography motility assay allowed the rapid assessment of
the motility of wild-type and mutant strains.
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(Table 2) using a qualitative microcinematography motility
assay (MMA). The HA-positive (HA+) M. gallisepticum
strain Rlow and its clonal variant RCL1, expressing the
major cytadherence gene gapA as well as the cytadherence-
related gene crmA, were capable of gliding. At any time,
60% of cells were moving, interrupted by short resting
periods. Mycoplasma gliding paths were visualized by
computer-generated overlay of all frames of a 3 min video
and consisted mainly of circles and bends (Figure 1). In
contrast, no gliding could be visualized for strains Rhigh,
RCL2, or mHAD3, which lack either GapA and/or CrmA.
These HA− strains appeared to have lost the ability to glide,
as no moving cells were observed in MMAs, in spite of nu-
merous trials under a variety of conditions.
Colonies of motile M. gallisepticum form microsatellites
Formation of microsatellites around colonies grown on
agar plates has been described for M. mobile [33] and
M. pneumoniae [16], and appears to be an indicator of
gliding motility in mycoplasmas. M. gallisepticum col-
onies have been reported to grow without satellite for-
mation under the conditions that allow M. mobile to
form microsatellites [33]. Conditions for microsatellite
formation by M. gallisepticum were established using
strains Rlow and Rhigh as prototypes of motile and non-
motile strains (Table 2). Diffuse colonies spreading in all
directions were observed for both strains when grown
on HFLX medium solidified with a range of concentra-
tions of agar (0.05 - 0.3%) (Figure 2). Higher concentra-
tions of agarose have already been shown to allow only
the formation of the typical fried-egg colonies and were
therefore not tested.
When M. gallisepticum cells were first allowed to at-
tach to the surface of a cell culture dish and then over-
laid with HFLX medium containing gelatin, motile
strains could be differentiated from non-motile strains
(Figure 2). At 0.5% gelatin, Rlow and Rhigh were not
able to form colonies on the bottom of the dish, but
cloudy regions in the overlay medium indicated that
mycoplasma cells had spread throughout the medium.Table 2 Protein content, motility and hemadsorption ability o
Strain Hem-adsorption Motility Cell Shape
Rlow ++ ++ flask
Rhigh - - round
RCL1 ++ ++ flask
RCL2 - - round
mHAD3 - - round
T932A + - rounded fla
T932C + - distorted fl
1trc; truncated.With increasing gelatin concentrations, the number of
colonies increased, while growth in the overlay medium
decreased. At 2% gelatin, the motile strains Rlow and
RCL1 formed round colonies with a smooth surface, sur-
rounded by many satellites, while the non-motile strains
Rhigh, RCL2, and mHAD3 formed colonies with a rough
surface, uneven edges, and without satellite colonies.
Higher concentrations of gelatin resulted in partial de-
tachment of colonies and formation of microcolonies in
the overlay medium. Therefore, for further experiments
to detect colonies of M. gallisepticum with a satellite-
growth altered (SGA) phenotype, HFLX medium solidi-
fied with 2% gelatin was used.
Generation of motility-deficient mutants and
complementation
To identify proteins involved in the gliding motility of M.
gallisepticum, RCL1 was transformed with transposonf MG strain
Presence of Reference
MGC2 GapA CrmA
+ + + [21]
+ - - [21]
+ + + [22]
+ - - [22]
+ (+) - [22]
sk - + + this study
ask trc1 + + this study
RCL1
mHAD3
0.5% 2% 0.1% 0.3%
HFLX / gelatine HFLX / agar
Figure 2 Morphology of M. gallisepticum colonies. Cultures of RCL1 and mHAD3 were either grown in HFLX medium solidified with 0.5 or 2%
gelatin or on low-agar plates containing 0.1 or 0.3% agar. In gelatin-containing medium, the non-motile strain mHAD3 formed compact colonies,
in contrast to the motile RCL1 which formed colonies surrounded by microsatellites.
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the SGA phenotype. In a proof-of-concept study, 4000
colonies were screened and 38 mutants were found to ex-
hibit defects in satellite colony formation. Their ability to
glide was further examined individually using MMAs.
Eight mutants had a low proportion of motile cells (20%),
so they were stored for later analysis. Southern blot ana-
lyses of thirty motility mutants found that the majority
carried multiple Tn4001cam insertions within their gen-
ome. Only ten mutants had contained only one or two
transposon insertions. They were subjected to LM-PCR to
precisely determine the transposon insertion sites. In four
mutants the transposon had integrated into the gapA
gene, and in another four mutants Tn4001cam was
inserted into the crmA gene (Figure 3). These mutants
were not analyzed further, because the same genes were
affected in the cytadherence-negative, non-motile strains
Rhigh, RCL2, and mHAD3. However, in two motility-
deficient mutants the transposon had integrated into
different sites in the mgc2 gene (also known as the
MGA_0932 coding region) and these mutant strains were
designated T932A and T932C (Figure 3). After filter clon-
ing, a LM-PCR analysis revealed that T932A contained
the Tn4001cam at position 222 517 (numbering according
to GenBank Accession AE015450.2) of the genomic DNA,
344 bp downstream of the initial coding nucleotide of the
mgc2 gene (Figure 3). The ORF therefore terminated 119
amino acids (aa) after the start codon, whereby the last 5
aa were encoded by the transposon. Even after repeated
filter cloning mutant T932C still appeared to contain two
transposons, one within the mgc2 gene at position 222
749, which would allow for translation of 193 aa of the
MGC2 protein. The second transposon was found in the
CRISPR region at position 930 903.
To confirm that disruption of the mgc2 ORF by trans-
position was responsible for the loss of motility, mutantsT932A and T932C were complemented with an mgc2-
6xHis fusion gene. For this purpose, the fusion gene was
subcloned into a derivative of plasmid pINT [27], which
integrates into the oriC region of M. gallisepticum
by homologous recombination. The resulting plasmid
p5Hmgc was introduced into the mutants by electropor-
ation, and the integration into the genomic oriC locus
was proven by Southern blot analyses.
Characterization of mgc2 mutants and complemented
mutants
Expression and surface localization of MGC2
The effect of transposon integration on expression of
mgc2 and the gapA and crmA genes immediately down-
stream of it was investigated by Western blot analyses.
For this purpose, polyvalent rabbit antisera against
MGC2, GapA and CrmA were produced. MGC2 was
equally well detected in HA+ and HA− M. gallisepticum
strains (Table 2). In contrast, no MGC2 could be de-
tected in T932A lysates (Figure 4A, lane 2), and only a
truncated MGC2, with an apparent size of 19 kDa,
was detected in T932C (Figure 4A, lane 3). When
complemented with p5Hmgc, both T932A and T932C
expressed full-length MGC2 at concentrations com-
parable to RCL1 (Figure 4A, lanes 4–5). The C-
terminal 6xHis-tag did not appear to influence the
stability of the recombinant MGC2.
As it has been suggested that the gapA transcript initi-
ates in the 3′ region of mgc2 [35], we analyzed the ex-
pression of gapA and crmA. Western blot analyses
revealed that expression of these genes did not appear to
be affected by the Tn4001cam insertion into mgc2, as
GapA and CrmA were detected at wild-type levels in
both the mgc2 mutants (Figures 4B and 4C).
MGC2 has been identified by immunoelectron micros-




Figure 3 Insertion sites of Tn4001cam transposon in motility mutants. Non-motile RCL1 mutants harbored transposons in the mgc
cytadherence locus, consisting of mgc2, gapA (formerly mgc1), and crmA (formerly mgc3). In mutants T932A and T932C Tn4001cam integrated
344 and 576 bp after the translational initiation nucleotide of mgc2.
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portion of MGC2, whole M. gallisepticum RCL1 cells
were incubated with trypsin for different time periods
and subjected to Western blot analyses with anti-MGC2
antiserum. Tryptic digestion produced a shorter frag-
ment of MGC2, migrating at an apparent molecular
mass of 31 kDa (Figure 4D), while untreated MGC2 mi-
grated at 33 kDa. The 31-kDa band was first detected
after 10 min of trypsin treatment (not shown), and be-
came more prominent with longer periods of digestion.
After 90 min of trypsin digestion the 33-kDa protein
was no longer detectable (Figure 4D), indicating the de-

























Figure 4 Absence of MGC2 protein in gliding mutants. Immunoblot an
(lane 3), and complemented mutants T932A::p5Hmgc (lane 4) and T932C::p
CrmA (C). No MGC2 was detected in T932A, and T932C weakly displayed a
full-length MGC2. Immunoblot analysis of whole cell lysates of RCL1 and m
after tryptic digest for 0 (T0), 40 (T1), and 90 min (T2); M, molecular weightthat trypsin digestion reduced the molecular weight of
MGC2 by only 2 kDa suggested that only a small region
of MGC2 was exposed on the surface. Trypsin digestion
patterns for the mgc2-complemented mutants T932A::
p5Hmgc and T932C::p5Hmgc were comparable to
those seen with RCL1 (Figure 4D), indicating the same
degree of surface localization of the 6xHis-tagged
MGC2 protein.
Hemadsorption activity
The hemadsorptive activity of wild-type strains, and
cytadherence and motility mutants was analyzed using a







T2 T0 T1 T2
alysis of RCL1 (lane 1), motility mutants T932A (lane 2) and T932C
5Hmgc (lane 5) with antibodies specific for MGC2 (A), GapA (B), and
truncated MGC2′, while RCL1 and complemented mutants produced
gc2-complemented mutants T932A::p5Hmgc and T932C::p5Hmgc (D)
marker.
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reported to be deficient in cytadherence [22], the col-
onies of the motility-impaired mgc2 mutants were able
to bind erythrocytes and thus these strains were HA+
(Table 2 and Additional file 1).
Cell morphology
Scanning electron microscopy revealed that the typical
flask shape of the wild-type strain Rlow (Figure 5A)
was altered in the non-motile, GapA and CrmA-
lacking strains Rhigh, RCL2 and mHAD3, which
consisted mainly of enlarged, rounded cells (Figures 5D-
F). The mgc2 mutant T932A appeared to have a smaller,
coccoid morphology (Figure 5B). However, flask-shaped
T932A cells with a slightly swollen body, but otherwise a
well-defined TO, were also present (Figure 5B, arrow and
Additional file 2). T932C had a wild-type flask shape ex-
cept for a distorted bulging middle region (Figure 5C). For
both mutants large spheroidal cells were also observed.
The TOs of the more rounded GapA/CrmA mutants were
generally not as well defined as in Rlow and T932C.
Gliding motility
Motility of T932A and T932C was assessed in at least 5
independent MMAs. Qualitative MMAs demonstrated
the impaired motility of the mgc2 mutants (Additional
file 3) compared to RCL1. In contrast to the large num-
ber of long gliding tracks seen with RCL1 (Figure 1),
only a very small proportion of the mgc2 mutants pro-




Figure 5 Morphology of M. gallisepticum strains. Scanning electron mic
with a pronounced TO (A, Rlow), while CrmA- (F, mHAD3) or GapA-deficient s
appearance with a less defined TO. Loss of MGC2 (B, T932A) or the presence
with either a rounded body or a flask shape-like morphology with bulges andcomplemented with mgc2-6xHis, these mutants were
able to glide again over long distances, comparable in
number and length to those of RCL1 (Additional file 3).
A quantitative MMA revealed that the mean gliding
distance for wild-type M. gallisepticum RCL1 was about
27.5 μm over a 3 min observation interval. The gliding
distances of the mutants T932A and T932C were signifi-
cantly reduced to 12.1 and 15.9% of this, respectively
(Figure 6A). The complemented strain T932A::p5Hmgc
reached 82.7% of the gliding distance of RCL1, while
T932C::p5Hmgc reached 63.9% of that of RCL1 (Figure 6A).
Statistical analysis revealed that the mean gliding distance
of complemented mutants was not significantly different
from that of RCL1.
A similar relationship was seen when the mean gliding
velocity over the same time interval was calculated.
RCL1 glided with a mean speed of 150 nm s−1. The mu-
tants T932A and T932C had a mean gliding velocity that
was significantly reduced to 16.7 and 25.9% of that of
RCL1, respectively, while mgc2-complementation re-
stored the mean velocity of the mutants back to 84.6
and 75.6% of that of RCL1 (Figure 6B).
Discussion
Not all bacteria are able to move. However, motile bac-
teria have a competitive advantage over their sessile rela-
tives: motility enables bacteria to reach and remain in
individual niches where they may find nutrients and/or
shelter from the host’s defense mechanisms. Various mo-
tility mechanisms have evolved to allow bacteria to swimmHAD3
T932C
roscopy revealed the typical M. gallisepticum flask-shape morphology
trains (D, Rhigh; E, RCL2) tended to have an enlarged, round-shaped
of a truncated MGC2 (C, T932C) resulted in an overall smaller appearance



























































Figure 6 Quantitative analysis of gliding motility. Time-lapse cinematography was performed for cultures of parental strain RCL1 and the
gliding-deficient transposon mutants (T932A, T932C) and mgc2-complemented mutants (T932A::p5Hmgc, T932C::p5Hmgc). Using the image
processing Fiji package, movies were analyzed to determine the gliding distance (A) and the average speed (B) of mycoplasmas. The mean
values from three independent experiments are shown. Statistically significant differences to RCL1 (P ≤ 0.05) are marked by asterisks.
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or glide over solid surfaces. Many phylogenetically unre-
lated bacteria have been shown to be able to glide, some,
like Neisseria and Pseudomonas, use surface appendices,
while others, like Flavobacterium and Myxococcus, glide
without any obvious locomotive structures [4]. Mycoplas-
mas are capable of gliding as well. In spite of the degen-
erative evolution process which shaped the Mycoplasma
genomes to a minimum size, gliding motility seems to be
essential for the parasitic life-style of some mycoplasmas.
Of the currently described 132 Mycoplasma species [37],
14 motile species are listed: M. agassizii, M. amphori-
forme, M. gallisepticum, M. genitalium, M. imitans, M.
insons, M. iowae, M. mobile, M. penetrans, M. pirum, M.
pneumoniae, M. pulmonis, M. testudineum, and M. testu-
dinis. Interestingly, most of these mycoplasmas wereeither originally isolated from the human or animal re-
spiratory tract, or they were at least occasionally recovered
from such samples. As the respiratory tract is well pro-
tected against incoming particles by a thick layer of mucus
and underlying epithelial cells covered with constantly
beating cilia, gliding motility might be essential to over-
come this mechanical barrier. The human pathogen M.
pneumoniae has been shown to bind initially to the apical
surface of ciliated human bronchial epithelial cells in vitro,
then to move down towards the base of ciliated cells be-
fore spreading [38]. M. pneumoniae mutants that are de-
fective in motility, but not in cytadherence, have impaired
capacity to colonize differentiated bronchial epithelium
in vitro [39], and these mutants cannot be recovered from
the lung tissue four days after inoculation, whereas motile
strains can be [40]. Gliding motility, therefore, seems to be
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tract, a first step in successful colonization of the host.
Contributing to mycoplasma pathogenesis, and being
at the same time a possible target for the development
of antimycoplasmal drugs, the elucidation of the myco-
plasma motility mechanism is of major importance. Even
though the gliding ability of the avian pathogen M. galli-
septicum was already observed in the 1970s [13], little
was known about the molecular basis of its motility.
Here, we report for the first time the involvement of
three proteins, MGC2, GapA and CrmA in the gliding
motility of M. gallisepticum.
Both, GapA and CrmA have been shown before to be
essential for cytadherence, colonization of the chicken
trachea and induction of host responses [41-43], while
mgc2 has mainly been used to differentiate M. gallisepti-
cum strains [44]. When M. gallisepticum strains from
our culture collection were analyzed for motility, gapA
mutants such as Rhigh and RCL2 were found to be non-
motile. The finding that GapA is involved in the gliding
mechanism of M. gallisepticum concords with data ob-
tained for M. pneumoniae. Addition of a monoclonal
antibody against the major cytadhesin of M. pneumo-
niae, P1, a homolog of GapA, removed gliding cells from
the glass, but did not interfere with the binding of non-
moving cells [34]. These data suggest that P1 has a cru-
cial role in gliding motility of M. pneumoniae, independ-
ent of its adhesion properties, but that adhesion is a
prerequisite for gliding [16,33,34,45]. Hasselbring et al.
found that all motility and HA mutant strains of M.
pneumoniae were able to bind to a glass surface [16].
Current models of the motility mechanism of M. pneu-
moniae suggest that P1 might serve as leg proteins that
attach to sialylated oligosaccharides on glass or animal
cells [46,47]. After binding to a solid support, with the
energy provided by ATP hydrolysis, the legs might re-
peatedly bind, pull, and release surface structures, thus
generating a continuous drag force that propels the cell
forward. Addition of free sialylated oligosaccharides in-
hibits the motility of M. pneumoniae cells, but not the
binding of non-gliding cells [47]. In our study, we simi-
larly observed that GapA-deficient strains of M. gallisep-
ticum lacked hemadsorption and motility, but were still
able to attach to glass (data not shown), indicating that
M. gallisepticum might be equipped with adhesion mole-
cules of differently functionality.
M. gallisepticum strain mHAD3, which is HA− and
non-motile, carries a transposon in crmA, which lies dir-
ectly downstream of gapA. The involvement of CrmA in
motility is in concord with findings on M. pneumoniae,
in which the orf6 gene, a homolog of crmA [48], has
been shown to be involved in motility. Mutant III-4,
which lacks the ORF6 cleavage products P40 and P90, is
non-motile [16]. Interestingly, P40 and P90 have beenshown to complex with P1 in chemical cross-linking
studies [49] and purified P1 and P90 have been found to
form complexes in vitro [50], suggesting that P1 physic-
ally interacts with P90 in the mycoplasma membrane.
Similarly, the M. genitalium proteins P110 and P140, ho-
mologs of GapA and CrmA, have been shown to be
cytadhesins required for TO development and to be re-
ciprocally dependent on each other for posttranslational
stability [51]. Such mutual dependence has also been re-
ported for GapA and CrmA in M. gallisepticum [22].
Mutations in gapA seem to have a polar effect on ex-
pression of crmA, as no CrmA is found in Rhigh or
RCL2 [22,43]. A reason for this might be the operon
structure of gapA/crmA (previously known as mgc1/
mgc3) as suggested by Keeler et al., who mapped the
transcriptional start site for these genes to the end of
upstream mgc2 [35]. However, loss of CrmA has a direct
negative impact on the level of GapA. In mHAD3, the
amount of GapA produced was greatly reduced [22],
possibly a result from accelerated turnover of GapA due
to the absence of its binding partner CrmA. However, a
mutual dependence of GapA/CrmA is not certain, be-
cause some transposon mutants in crmA were reported
to express GapA [41,52]. On the other hand, these
transposon mutants were not analyzed for C-terminally
truncated CrmA fragments, which might be sufficient to
stabilize GapA. Knock-out of either gapA or crmA,
therefore, might have an impact on expression of both
proteins, and, as a consequence, it might be difficult to
dissect whether the loss of motility in Rhigh, RCL2 or
mHAD3 is attributable to the loss of GapA or CrmA.
To add another level of complexity, mutations in gapA
or crmA have been shown to affect the morphology of M.
gallisepticum. Our electron microscopy studies revealed
that the typical flask-shaped appearance of M. gallisepti-
cum, presenting a defined single knob-like structure at
one polar end, changed to a rounder, bulkier morphology,
with less defined tip structures in strains lacking GapA
and CrmA. Similarly, M. pneumoniae mutant M5 which
had lost the homolog of CrmA exhibits a perfect round
cell shape, but has lost the tip-like structure [53]. Mutants
of M. pneumoniae lacking homologs of GapA and CrmA
also have lost the elongated flask-shape and display a
branched cell morphology [54]. Our findings support a
direct link between the major adhesin and the gliding
mechanism. However, the question remains whether loss
of GapA leads to a loss of motility because GapA cannot
act any longer as the “leg” adhesin for the “bind-and-re-
lease”-cycles of gliding, or because loss of GapA leads to a
drastically changed morphology with conceivable conse-
quences on the correct positioning of any locomotive
regions. As the correct morphology may be a strict re-
quirement for the gliding process, future work should
focus on the creation of defined M. gallisepticum mutants
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tual interference on expression of each other and a defined
effect on only morphology, cytadherence, or motility.
To identify other genes involved in motility, we con-
structed a transposon by exchanging the gentamicin
resistance gene in Tn4001mod [28] with the gene for
chloramphenicol resistance, envisaging future needs
such as assessing transposon mutants in gentamicin-
based cell invasion assays. The chloramphenicol resist-
ance gene of plasmid pACYC184 was effective when
placed behind the MG tufPO, which has previously been
shown to function as an effective transcriptional pro-
moter [27]. Stability assays showed that transposon
mutants of M. gallisepticum could be cultivated for 20
passages without antibiotic selection pressure. No re-
transposition or excision of Tn4001cam could be de-
tected (data not shown). However, a drawback of this,
and presumably any Tn4001-based transposon strategy,
was the transposon’s tendency to integrate into multiple
genomic sites simultaneously. Around 60% of our mu-
tants were not further analyzed because they carried
multiple insertions of Tn4001cam. The limited number
of mutants analyzed in this study suggests that other
genes involved in motility might be identified using a
similar, more optimized approach. Recently, a mariner-
based transposon was reported to produce mutants in
M. hyopneumoniae with stable single insertions [55].
Use of a similar transposon would ensure that each mu-
tant could be used for analysis.
Screening of a small transposon mutant library led to
the identification of mgc2 as a major motility gene. Loss
of MGC2 resulted in a drastic reduction in motility
(Figure 6) that could be restored by complementation of
the mutants with a recombinant mgc2-6xHis gene. In
contrast to the non-motile gapA/crmA mutants Rhigh,
RCL2 and mHAD3, the mgc2 mutation in T932A or
T932C did not influence the presence of GapA or
CrmA, and the cellular morphology was not as drastic-
ally altered as in the GapA/CrmA-deficient mutants.
After carefully analyzing many electron micrographs, it
seems that both mgc2 mutants had a flask-shaped
morphology similar to that of RCL1, characterized by
the presence of a short TO (Figure 5). The majority of
T932A cells appeared as coccoid cells, possibly a conse-
quence of T932A binding almost exclusively via the TO
to the glass slide surface. The flask-shaped T932A is
then viewed along its longitudinal axis, with the distal
end of the body orientated to the viewer and only virtu-
ally pretending a coccoid morphology. Occasionally, a
TO became visible below the spherical body, bent to-
wards the glass surface (Additional files 2A, B; indicated
by arrows).
The ability to cytadhere, as measured by the HA assay,
was not affected by the loss of MGC2 in T932A orT932C. This is in contrast to the first report about
MGC2, which was classified as a cytadhesin [36], pri-
marily based on the strong homology between MGC2
and the M. pneumoniae cytadhesin P30, and on attach-
ment inhibition assays. Composed of an N-terminal do-
main I which is likely to be localized in the cytoplasm, a
transmembrane region, a surface-exposed domain II,
and highly repetitive, proline-rich domain III [56], P30
has been shown to be a membrane protein that co-
localizes with the major cytadhesin P1 to the TO of M.
pneumoniae [57]. MGC2 shares with P30 the same
overall domain architecture [36,56], a similar size, and
40.9% amino acid sequence identity [36]. Specifically the
transmembrane region and domain II are highly con-
served between M. pneumoniae P30 and M. gallisepticum
MGC2 [56]. Another coincidence is that P30 mutations
have effects on cell morphology, cytadherence, motility
and virulence [46]. The P30 null mutant II-3 has an ovoid,
branched shape, has no ability to hemadsorb [58] nor glide
[16], although all other cytadherence-related proteins,
such as P1 and the cytadherence accessory proteins, are
synthesized as usual [59]. Complementation of the II-3
mutant with the gene encoding P30 rescued the wild-type
phenotype [46]. P30 mutations have an impact on the sta-
bility of P65 which is located at the distal end of the TO.
P65 is involved in cytadherence and motility, and is
thought to form a complex with P30 [60]. It would be
interesting to investigate whether the reported reciprocal
requirement for stabilization between P65 and P30 also
exists between MGC2 and PlpA, the ortholog of P65 in
M. gallisepticum.
A striking difference between P30 and MGC2 is its
impact on cytadherence. In contrast to the HA− P30
mutants of M. pneumoniae, the MGC2-deficient M.
gallisepticum mutants were still able to hemadsorb. The
binding of erythrocytes seemed to primarily depend on
the presence of GapA or CrmA (Table 2). As the mgc2
mutations did not have any polar effects on the expression
of gapA or crmA, there was no influence on hemadsorp-
tion. However, the first description of MGC2 reported that
MGC2-specific antiserum was able to reduce the attach-
ment of M. gallisepticum to CEF cells by 30 to 48% [36].
The lack of complete inhibition was attributed to the ex-
istence of additional adhesins such as hemagglutinin VhlA
(pMGA) or GapA (MGC1). Although HA has been widely
used as an assay for cytadherence [3], the inhibition of at-
tachment to CEF cells by MGC2-specific antibodies might
not necessarily prove that MGC2 is a cytadhesin. This
protein, as shown by our trypsinization assays, has a very
small extracellular domain, and we hypothesize that
MGC2 is rather linking internal components of the loco-
motive machinery to another external adhesion compo-
nent. GapA could be the external adhesion component in
analogy to the proposed leg protein P1 of M. pneumoniae
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tions due to the close connection between MGC2 and the
putative leg protein, thus causing only moderate inhibition
of attachment.
We have shown the genes of the mgc locus [35], mgc2,
gapA, and crmA, to be involved in motility of M. galli-
septicum. It is of particular importance that mgc2 is not
involved in hemadsorption. This will enable us to study
these two mechanisms, hemadsorption and motility, in-
dependently in M. gallisepticum.
Additional files
Additional file 1: Qualitative HA assessment of wild-type and
gliding mutants. Colonies of RCL1 and motility mutants T932A and
T932C were grown on agar plates and overlaid with sheep erythrocytes.
No remarkable difference in hemadsorption was seen between wild-type
RCL1 and mgc2 mutant strains.
Additional file 2: SEM pictures of M. gallisepticum motility mutants.
Mutant T932A (A, B) partly appeared as small spheres without a TO. In
some cases TOs seemed to be placed between the glass surface and
the main body of the mycoplasma cell (arrows), indicating that T932A
had attached to the glass via the TO, therefore appearing spherical.
Interestingly, in T932C (C) large spheroid cells with TO structures were
also seen (triangle).
Additional file 3: Gliding paths of M. gallisepticum motility mutants
before and after complementation. Only short gliding paths were
seen, if any, in mgc2 motility mutants (T932A and T932C), while the
complementation of the mutants with mgc2 (T932A::p5Hmgc and
T932C::p5Hmgc) restored the gliding motility to almost wild-type
levels (see Figure 1).
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